Novel biomarkers and the outcome from critical illness and major surgery

Abstract

As the molecular basis for disease becomes better understood the importance of biomarkers continues to grow. Novel techniques have led to the identification of large numbers of biologically significant compounds that could act as biomarkers. The appeal of these as diagnostic and therapeutic markers is obvious but the choice of marker for everyday clinical practice is not. © 2007 Springer Science + Business Media Inc.